Diabetes (DM) as well as obesity, due to their increasing incidence, were recognized as
epidemic by the World Health Organization. Obesity is involved not only in the …

There is a rising trend of overweight and obesity among individuals with type 1 diabetes.
This is often associated with insulin resistance, increased insulin dose requirements and …

The current classification system presents challenges to the diagnosis and treatment of
patients with diabetes mellitus (DM), in part due to its conflicting and confounding definitions …

Objective. Several clinical studies have reported the application of dipeptidyl peptidase‐4
(DPP‐4) inhibitors as treatments for type 1 diabetes mellitus (T1DM). This study aims to …

Background Resveratrol is a natural polyphenol that has been proposed to improve
glycemic control in diabetes, by mechanisms that involve improvement in insulin secretion …

Abstract Aims/Introduction Several clinical trials reported the effects of sodium–glucose
cotransporter (SGLT) inhibitors in type 1 diabetes patients. This meta‐analysis aimed to …

Background Many people living with type 1 diabetes (type 1 diabetes mellitus (T1DM)) do
not meet glycaemic targets. Adjunctive therapies have both risks and metabolic benefits and …

Introduction Despite significant strides made in the management of T1DM, standard
management is still insulin analog therapy. Some non-insulin therapies traditionally …

Diabetic nephropathy is characterized by excessive accumulation of extracellular matrix
(ECM) leading to renal fibrosis, progressive deterioration of renal function, and eventually to …

Use of sodium glucose cotransporter (SGLT) inhibitors are a well‐established therapeutic
option in type 2 diabetes (T2D) with a variety of proven therapeutic benefits. They have …